Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Andrin Good"'
Autor:
Lisa Baumgartner, Gianluca Galeno, Florian A. F. Schuler, Andrin Good, Carlijn R. Hooijmans, Benjamin V. Ineichen, Tarzis Jung, Rob B. M. de Vries, Marc P. Schneider, Martin Hlavica, Nicolas Good
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-17 (2019)
Hooijmans, Carlijn R; Hlavica, Martin; Schuler, Florian; Good, Nicolas; Good, Andrin; Baumgartner, Lisa; Galeno, Gianluca; Schneider, Marc P; Jung, Tarzis; de Vries, Rob; Ineichen, Benjamin V (2019). Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Scientific reports, 9(1), p. 822. Springer Nature 10.1038/s41598-018-35734-4
Scientific Reports
Scientific Reports, 9
Scientific Reports, 9 (1)
Hooijmans, Carlijn R; Hlavica, Martin; Schuler, Florian; Good, Nicolas; Good, Andrin; Baumgartner, Lisa; Galeno, Gianluca; Schneider, Marc P; Jung, Tarzis; de Vries, Rob; Ineichen, Benjamin V (2019). Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis. Scientific reports, 9(1), p. 822. Springer Nature 10.1038/s41598-018-35734-4
Scientific Reports
Scientific Reports, 9
Scientific Reports, 9 (1)
An unmet but urgent medical need is the development of myelin repair promoting therapies for Multiple Sclerosis (MS). Many such therapies have been pre-clinically tested using different models of toxic demyelination such as cuprizone, ethidium bromid
Autor:
Dianne P. Figlewicz, Martin E. Schwab, Nicolas Good, Maryam S. Seyedsadr, Martin Hlavica, Aro Delparente, Andrin Good, Benjamin V. Ineichen, Patricia S. Plattner
Publikováno v:
Neuroscience Letters. 648:41-46
One main pathological hallmark of multiple sclerosis (MS) is demyelination. Novel therapies which enhance myelin repair are urgently needed. Insulin and insulin-like growth factor 1 (IGF-1) have strong functional relationships. Here, we addressed the